Cavan, Yvrej Kier C.
HRN: 21-73-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2024
CEFUROXIME 1.5GM (VIAL)
05/24/2024
05/30/2024
IVT
430mg
Q8
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes